Original news and analysis on international IP policy
BASEL -- Students from around the world are gathering momentum to challenge their universities’ licensing policies and research and development systems. That was one of the messages emerging from the annual meeting of Universities Allied for Essential Medicines (UAEM) Europe.
As the future United Nations development goals are being debated and decided, two important reports make the case for inclusion of a discussion on global governance and its impact on health.
The potential for big data to yield better outcomes in all aspects of health is tremendous, and tapping into it has only just begun, said speakers at a recent panel in Geneva.
An investment policy review undertaken by the United Nations Conference on Trade and Development (UNCTAD) found that Bangladesh needs to attract foreign direct investment to sustain its development and suggests that the country loosen its grip on the pharmaceutical sector. Bangladesh said the review will be carefully considered.
The World Trade Organization Dispute Settlement Body yesterday agreed to establish two more panels in a dispute against Australia's plain packaging for tobacco products, bringing the total to five. And it was agreed that a single panel will be appointed to study the five complaints.
Greg Perry has been executive director of the Medicines Patent Pool (MPP) for over a year now, since January 2013. Under his guidance, MPP shares that it has launched a “series of new licensing agreements and negotiations with key patent holders and generic medicines companies.” Intellectual Property Watch sat down with Perry recently to discuss why the MPP is so important as an alternative business model, the context of the MPP, changes in the global approach to the issue of access, and how the MPP fits within the Geneva context.
Non-communicable diseases, access and affordability, global health governance and information and communications technology innovation are some of the important issues discussed and debated at the recent Geneva Health Forum (GHF).
Public institutions often appear as lagging behind the private sector in innovation, especially in medical and healthcare science. But for the past decade, numerous international projects in public hospitals have included innovation as a driving force in their overall strategy development, according to speakers at a recent panel.
The Geneva Health Forum (GHF), taking place on 15-17 April in Geneva, will discuss the theme “Global Health: Interconnected Challenges, Integrated Solutions.” This year’s forum aims to encourage an “integrative approach” to global health, “which better captures the underlying causes of ill-health and recognises the commonalities that underlie people’s health around the world,” says GHF.
KAMPALA - As the East African Community nears full revival, a bloc market covering five countries with a population of about 145 million people has emerged. But the member countries face another challenge: they have different levels of intellectual property rights protection.
Guidelines for the treatment of hepatitis C released by the World Health Organization today recommend revolutionary new drugs for the virus. However, the exorbitant price of these drugs means they will remain out of reach for most of the millions infected. The WHO guidelines themselves offer limited recommendation for reducing prices, but may help in creating the conditions for price reduction by accruing demand and giving countries official backing in price negotiations.
South Africa’s upcoming general elections on 7 May have thrown a spanner in the works of the much-anticipated national draft intellectual property policy from coming into effect anytime soon.